Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
Arrigo F.G. Cicero, Federica Fogacci, Masanari Kuwabara, et al.
Medicina (2021) Vol. 57, Iss. 1, pp. 58-58
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
Arrigo F.G. Cicero, Federica Fogacci, Valentina Di Micoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7027-7027
Open Access | Times Cited: 41
Live and pasteurized Akkermansia muciniphila attenuate hyperuricemia in mice through modulating uric acid metabolism, inflammation, and gut microbiota
Lihua Zhang, Jiaxiu Liu, Tong Jin, et al.
Food & Function (2022) Vol. 13, Iss. 23, pp. 12412-12425
Closed Access | Times Cited: 39
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation
Alessandro Maloberti, Alessandro Mengozzi, Elisa Russo, et al.
High Blood Pressure & Cardiovascular Prevention (2023) Vol. 30, Iss. 5, pp. 411-425
Open Access | Times Cited: 35
Advances in pharmacotherapies for hyperuricemia
Federica Piani, Davide Agnoletti, Claudio Borghi
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 737-745
Closed Access | Times Cited: 25
Structural basis for urate recognition and apigenin inhibition of human GLUT9
Zilin Shen, Xu Li, Tong Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
The role of alcohol consumption in pathogenesis of gout
Barbara Nieradko‐Iwanicka
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 25, pp. 7129-7137
Closed Access | Times Cited: 55
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
Letizia Polito, Massimo Bortolotti, Maria Giulia Battelli, et al.
Redox Biology (2021) Vol. 48, pp. 102195-102195
Open Access | Times Cited: 54
Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Review of Urate-Lowering Therapeutics: From the Past to the Future
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Mechanisms of theaflavins against gout and strategies for improving the bioavailability
Jingzi Chen, Yanchao Zheng, Sihan Gong, et al.
Phytomedicine (2023) Vol. 114, pp. 154782-154782
Closed Access | Times Cited: 19
Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis
Alfredo G. Casanova, Ana I. Morales, Laura Vicente-Vicente, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Long-term hyperuricemia impact on atrial fibrillation outcomes
Aurelio Quesada, Javier Quesada-Ocete, Blanca Quesada-Ocete, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 7, pp. 102608-102608
Closed Access | Times Cited: 7
Investigating the effects of rare ginsenosides on hyperuricemia and associated sperm damage via nontargeted metabolomics and gut microbiota
Xueying Ji, Lingbo Yu, Chengcheng Han, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118362-118362
Closed Access | Times Cited: 6
Mechanism of Lacticaseibacillus rhamnosus JY027 alleviating hyperuricemia in mice through gut-kidney axis
Chao Miao, Kai Dong, Yu Shen, et al.
Food Bioscience (2024) Vol. 61, pp. 104757-104757
Closed Access | Times Cited: 6
Xanthine oxidase inhibitory study of eight structurally diverse phenolic compounds
Arshad Mehmood, Jiayi Li, Ashfaq Ur Rehman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 24
Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout
Zihan Hou, Aijinxiu Ma, Jiale Mao, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 895-909
Closed Access | Times Cited: 14
Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice
Zhihuan Wang, Liqiong Song, Xianping Li, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study
Yuki Ohashi, Hiroshi Ooyama, Hideki Makinoshima, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 300-300
Open Access | Times Cited: 5
Understanding Hyperuricemia: Pathogenesis, Potential Therapeutic Role of Bioactive Peptides, and Assessing Bioactive Peptide Advantages and Challenges
Yanchao Chen, Jing Yang, Qinchun Rao, et al.
Foods (2023) Vol. 12, Iss. 24, pp. 4465-4465
Open Access | Times Cited: 12
Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach
Yedi Herdiana, Yoga Windhu Wardhana, Insan Sunan Kurniawansyah, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 102-102
Open Access
Inhibitory Effect of Whey Protein‐Derived Peptide Leu‐Asp‐Gln‐Trp on Xanthine Oxidase
Kazuya Toda, Masaki Kurimoto, Yuma Hirose, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 4
Open Access
Eurycomanol alleviates hyperuricemia by promoting uric acid excretion and reducing purine synthesis
Ruixia Bao, Qian Chen, Zheng Li, et al.
Phytomedicine (2021) Vol. 96, pp. 153850-153850
Closed Access | Times Cited: 25
Combination of Uric Acid and Pro-Inflammatory Cytokines in Discriminating Patients with Gout from Healthy Controls
Xuwen Zha, Bo Yang, Guangyun Xia, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1413-1420
Open Access | Times Cited: 16
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
Jackelyn Murray, Harrison C. Bergeron, Les Jones, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 912-912
Open Access | Times Cited: 16
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Song Ke, Ming He, Xiangxin Kong, et al.
BMC Surgery (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top